Atrium Therapeutics, Inc. (RNA) on GreekSoup https://greeksoup.ai/stocks/us/rna/ Every dated entry in the public record on Atrium Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Sat, 31 Oct 2026 00:00:00 +0000 Atrium Therapeutics, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/rna/filings/us:RNA:filing:2026-10-27:e4a904f76cTue, 27 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc.: short interest 3,726,302 shares at the 15 October 2026 settlement, 12.94 days to coverhttps://greeksoup.ai/stocks/us/rna/short-interest/us:RNA:short-interest:2026-10-15:fff866a140Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc. filed 8-K/A: other eventshttps://greeksoup.ai/stocks/us/rna/filings/us:RNA:filing:2026-10-09:b3dcb741c3Fri, 09 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc. filed 8-K: material agreement, unregistered sale of equity, other eventshttps://greeksoup.ai/stocks/us/rna/filings/us:RNA:filing:2026-10-08:7b74126de1Thu, 08 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc.: short interest 3,395,873 shares at the 30 September 2026 settlement, 8.27 days to coverhttps://greeksoup.ai/stocks/us/rna/short-interest/us:RNA:short-interest:2026-09-30:47b045e0e5Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc.: short interest 3,397,791 shares at the 15 September 2026 settlement, 8.15 days to coverhttps://greeksoup.ai/stocks/us/rna/short-interest/us:RNA:short-interest:2026-09-15:429174e099Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc.: short interest 3,351,526 shares at the 31 August 2026 settlement, 19.79 days to coverhttps://greeksoup.ai/stocks/us/rna/short-interest/us:RNA:short-interest:2026-08-31:81021f4583Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc.: Schedule 13G/A filed by RA Capital Management, L.P., 0.0% of the classhttps://greeksoup.ai/stocks/us/rna/holders/us:RNA:schedule-13:2026-08-14:b2da406232Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc.: Schedule 13G filed by Sessa Capital IM, L.P., 8.8% of the classhttps://greeksoup.ai/stocks/us/rna/holders/us:RNA:schedule-13:2026-08-14:ee17ad8498Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc.: Schedule 13G/A filed by T. Rowe Price Associates, Inc., 8.6% of the classhttps://greeksoup.ai/stocks/us/rna/holders/us:RNA:schedule-13:2026-08-14:7f3e1854faFri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc.: short interest 3,480,849 shares at the 14 August 2026 settlement, 27.46 days to coverhttps://greeksoup.ai/stocks/us/rna/short-interest/us:RNA:short-interest:2026-08-14:b61d66d5b7Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc. Q2 FY2025 results: revenue $4 million, net income -$13 millionhttps://greeksoup.ai/stocks/us/rna/results/fy2025-q2/us:RNA:result:2026-08-13:45b7b6b05cThu, 13 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc. Q2 FY2026 results: revenue $3 million, net income -$20 millionhttps://greeksoup.ai/stocks/us/rna/results/fy2026-q2/us:RNA:result:2026-08-13:32a88cf20dThu, 13 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/rna/filings/us:RNA:filing:2026-08-13:753204910aThu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Atrium Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/rna/filings/us:RNA:filing:2026-08-13:deae0d70cdThu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>